日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical characterization of [(18)F]D(2)-LW223: an improved metabolically stable PET tracer for imaging the translocator protein 18 kDa (TSPO) in neuroinflammatory rodent models and non-human primates.

[(18)F]D(2)-LW223 的临床前表征:一种改进的代谢稳定 PET 示踪剂,用于在神经炎症啮齿动物模型和非人灵长类动物中对转运蛋白 18 kDa (TSPO) 进行成像

Liao Kai, Chen Jia-Hui, Ma Jie, Dong Chen-Chen, Bi Chun-Yang, Gao Ya-Biao, Jiang Yuan-Fang, Wang Tao, Wei Hui-Yi, Hou Lu, Hu Jun-Qi, Wei Jun-Jie, Zeng Chun-Yuan, Li Yin-Long, Yan Sen, Xu Hao, Liang Steven H, Wang Lu

Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism

多囊卵巢综合征中SFRP5水平降低与过度代谢炎症相关,而二甲双胍可逆转这一现象:提示SFRP5在代谢紊乱中发挥作用。

Zhang, Yi; Ran, Yuxin; Kong, Lingna; Geng, Lihong; Huang, Hua; Zhang, Hongying; Hu, Jun; Qi, Hongbo; Chen, Ying

Correction to: Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism

更正:SFRP5 水平降低与多囊卵巢综合征中过度代谢炎症相关,二甲双胍可逆转此现象:提示其在代谢紊乱中的作用

Zhang, Yi; Ran, Yuxin; Kong, Lingna; Geng, Lihong; Huang, Hua; Zhang, Hongying; Hu, Jun; Qi, Hongbo; Chen, Ying